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Objectives: Overuse of health services is increasingly recognized as a problem that 
affects both quality and costs of health care. An important next step to measuring 
overuse is identification of appropriate datasets. Our study evaluated the potential 
of using health insurance claims data to document the use and associated spend-
ing of services identified by clinical guidelines as having low-value. MethOds: 
Claims data from a not-for-profit Upper Midwest health insurance plan serving 1.6 
million enrollees in 2011 were analyzed to determine the potential for quantifying 
the inappropriate use of four low-value services endorsed by the Choosing Wisely 
initiative. The services included: 1) Imaging studies for acute non-specific low back 
pain, 2) Pap-test cervical cancer screening for women younger than 21 years, 3) 
Prostate-specific antigen screening for prostate cancer for men older than 75 years, 
and 4) Screening colonoscopy for adults older than 75 years. Results: Only 4% of 
the patients with low back pain received an MRI within six weeks of diagnosis. PSA 
tests for men over 75 years old were somewhat higher (8%), but the unit cost for 
these procedures was only $27. Three percent of enrollees over 75 years old had 
colonoscopies and inappropriate Pap tests were about 2%. cOnclusiOns: While 
we have been able to demonstrate how a private sector health plan can monitor 
the use of low-value services. The savings that this health plan can achieve is less 
than expected and less than other recent national estimates. Consequently the 
use rates appear to be much higher in other geographic locations where there are 
fewer large multi-specialty group practices with extensive quality assurance pro-
grams in place. Health plan claims data capture services for patients regardless of 
where the care is obtained. We can analyze the influence of patients and providers 
characteristics associated with low-value services and informed clinical and policy 
interventions can be developed.
PHS173
initiation and evaluation of clinical PHarMacy ServiceS to 
Surgical ward in a SoutH indian tertiary care teacHing HoSPital
Adepu R., Sharon S.
JSS University, Mysore, India
Objectives: To assess the usefulness of clinical pharmacy services in surgery 
department of a tertiary care teaching hospital in South India MethOds: With 
initial briefing about clinical pharmacy services and consent from the Chair, 
Surgery department, Clinical Pharmacy Services were offered for a period of six 
months. The services offered were drug information, detection, monitoring and 
reporting of adverse drug reactions, patient counseling and therapeutic interven-
tions. Usefulness of the services was evaluated at the end of the study period using 
descriptive statistics. Results: During the study period, a total of 526 clinical 
pharmacy services were provided to the surgery department. Among them 38.02% 
account for adverse drug reactions followed by 27.19% drug information, 22.05% 
patient counseling and 12.73% of pharmacist interventions for rationalizing drug 
therapy. Among the ADRs, vomiting (29.50%), diarrhea (17.50%), neutropenia (16.50%) 
were the major ADRs detected. Majority drug information provided was chemo-
therapy protocols (68.53%) followed by dosage and administration of drugs (13.98%). 
Counselling services was offered to patients with diabetic foot infections (27.58%), 
cellulitis (21.55%), appendicitis (12.93%), and pancreatitis (10.34%). Pharmacist 
intervention was found to be highest for untreated indication (46.26%) followed 
by dosage adjustment in renal impairement (14.92%), and dosage adjustment in 
hepatic impairement (11.94%). The overall satisfaction rate was found to be 8 out of 
10 scale. cOnclusiOns: Clinical pharmacy services offered to surgery department 
helped in improving overall patient care and clinician satisfaction
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Objectives: Follow-up after hospitalization for mental illness is a standard HEDIS 
(Healthcare Effectiveness Data and Information Set) quality indicator that may 
affect risk of relapse. This study evaluated rates of follow-up visits and implications 
for re-admissions for patients with schizophrenia or bipolar disorder using admin-
istrative claims data. MethOds: A cross-sectional analysis of Optum Clinformatics 
data (1/1/2013–12/31/2013) was completed for two cohorts – schizophrenia (with or 
without bipolar) and bipolar only. Schizophrenia patients were required to have ≥ 1 
inpatient or ≥ 2 outpatient claims for schizophrenia and ≥ 1 antipsychotic medica-
tion claim. Bipolar patients were required to meet the same criteria and also be≥ 18 
years old. Patients were identified as having follow-up after a psychiatric-related 
hospitalization if they had an outpatient visit with a psychiatric diagnosis within 
7 days of discharge of each psychiatric hospitalization they had in the analysis 
period. Logistic regression analysis was undertaken to assess the effects of a 7-day 
outpatient follow-up visit on likelihood of readmission, controlling for age, sex, 
substance abuse, other psychosis, antipsychotic MPR, and use of antidepressants, 
anxiolytics, anticonvulsants, and mood altering drugs. Results: The schizophrenia 
cohort (N= 4,164) had mean (SD) age of 36.9 years (15.6), 51.2% had other psychosis, 
and 43.2% had a psychiatric hospitalization. The bipolar cohort (N= 21,768) had mean 
(SD) age of 40.0 years (13.1), 40.0% had other psychosis, and 28.0% had a psychiat-
ric hospitalization. Among patients with ≥ 1 psychiatric hospitalization, 30.3% and 
32.9% had outpatient follow-up visits within 7 days in the schizophrenia and bipolar 
cohorts, respectively. Using multivariate analysis, patients with follow-up within 7 
days of discharge had a > 50% reduction in likelihood of 30-day re-admission in both 
cohorts (Schizophrenia: OR= 0.40; 95% CI= 0.31-0.51; p< 0.0001 and Bipolar: OR= 0.46; 
health institutions of Tigray Region, Ethiopia. MethOds: A health institution 
based quantitative and qualitative cross-sectional study was conducted among 
845 pregnant women and 72 healthcare providers, from March to June 2012. The 
sample size was divided among twelve health facilities proportional to the total 
number of pregnant mothers in the facilities and selected by systematic sampling 
technique. Quantitative data were collected by trained data collectors through 
face-to-face interview of pregnant mothers using pre-tested, semi-structured 
questionnaire. In-depth interviews with healthcare providers and 11 focus group 
discussions of 108 clients were used to collect qualitative data. Logistic regression 
test was employed to assess determinants of client satisfaction. Results: 702 
(83.1%) of the pregnant women were tested for HIV after pre-counseling; 1.6% of 
which were positive. Average client’s waiting and counseling time were found to 
be 26.4 minutes and 10.7 minutes, respectively. 48% of PMTCT service recipient 
mothers reported being satisfied with the service. The results of the qualitative 
study indicated that major barriers for PMTCT implementation were unfavorable 
attitude toward PMTCT, distance of health facilities, loss to follow up and non-
adherence. Repeatedly mentioned health professionals related barriers were lack 
of on job training to update themselves and absence of incentive for the additional 
workload. After adjusting for independent variables, waiting time of longer than 15 
minutes (AOR 2.32, 95%CI 1.53-4.78) was found to be associated with lesser clients’ 
satisfaction. cOnclusiOns: Overall quality of PMTCT service was found to be 
low in terms of waiting time length, duration of stay with healthcare providers 
and clients’ satisfaction. Giving trainings and incentivizing healthcare provid-
ers, educating clients and improving the accessibility of service would help to 
minimize PMTCT implementation barriers thereby contributing to better service 
quality.
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Objectives: The Centers for Medicare and Medicaid (CMS) core set of quality 
measures for use in Medicaid and the Children’s Health Insurance Program (CHIP) 
includes a measure for follow-up care within 30 days of a child initiating treatment 
with an attention deficit disorder (ADHD) medication. The objective of this study 
is to document the proportion of children in Mississippi Medicaid who received 
a follow-up visit within 30 days of initiating a stimulant for ADHD. MethOds: A 
retrospective analysis was conducted using Mississippi Medicaid medical claims, 
pharmacy claims and beneficiary eligibility data for the time period July 2012 to 
December 2013. 2013 was the observation year for initiation of stimulant therapy. 
Inclusion criteria were age < 21 at time of initiation of therapy, continuously 
enrolled for 180 days prior and 30 days post prescription start index date (PSID), 
and PSID occurred during observation year. Beneficiaries were considered to have 
received follow-up if a claim for an office visit occurred within 30 days of the 
PSID. Results: 6,354 children met the inclusion criteria and 3,769 (59.3%) had 
a follow up visit within 30 days. The prescribing physicians were primary care 
physicians (PCPs) for 49.5% of patients, psychiatrists for 23.2%, and other types of 
prescribers 27.3% of the time. PCPs had the lowest rate of follow up visits; 51.0% 
compared to 55.6% for psychiatrists and 54.1% for other prescribers. There was 
considerable variability in rates for MDs in each provider type. cOnclusiOns: The 
Mississippi rate of 59% follow up is above the national average of 46% reported in 
the 2014 CMS Annual report on child quality measurement for FFY 2013. Although 
PCPs had the lowest rate, all provider types needed improvement on this meas-
ure. Educational interventions are needed to improve the state’s performance 
on this measure.
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diSeaSe-SPecific diStribution of HealtH care Quality MeaSureS in 
tHe united StateS
Nicholson G.L., Halbert R.J.
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Objectives: Quality improvement initiatives in US health care increasingly focus 
on physician and hospital performance against rigorous, evidence-based quality 
measures (QMs). Over the last decade, the universe of QMs has grown exponen-
tially and continues to grow. We examined the landscape of current QMs across 
multiple diseases to better understand the evolving nature of quality measure-
ment. MethOds: Publicly available databases of QMs were searched to identify 
indicators in a wide range of disease states over a period of 3 years. All identified 
QMs were bundled by disease area and plotted on a landscape matrix, assessing 
the maturity of quality science and burden of disease (based on prevalence, pub-
lic health impact, and cost). The distribution of QMs in the matrix was validated 
through in-depth interviews with payers (n= 20) and providers (n= 7). Results: QMs 
in disease areas with low disease burden and immature quality science (e.g., schizo-
phrenia) are rare or non-existent. Disease areas with significant disease burden but 
less developed quality science (e.g., oncology) have relatively few QMs in adoption 
but are rapidly adding new QMs and refining current QMs. High-burden diseases 
with mature quality science (e.g., diabetes) have multiple QMs that are well-
entrenched and stable, with relatively less addition or refinement. Findings from 
the landscape matrix exercise were validated through interviews with payers and 
provider groups, focusing on their current and future quality improvement agendas, 
and quality activities linked to incentives. cOnclusiOns: Implementation of qual-
ity measures varies by disease state characteristics, including public health impact 
and the maturity of measurement science. A tight focus on producing new metrics 
may not be the best way to advance quality in every area. For some diseases, efforts 
may be more productive if directed toward strengthening the quality infrastructure. 
Examples include improving measurement capability, establishing quality domains, 
or standardizing clinical practice guidelines.
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ACOs experienced a 1.95% increase in cost per discharge between 2011 and 2012, 
while cost per discharge among jointly-led ACOs fell by only 1.27%. Analysis of in-
hospital mortality rates did not reveal persistent trend differences. cOnclusiOns: 
Hospitals that adopted the ACO model had more favorable cost trends between 2008 
and 2011 than hospitals that did not adopt the model, which suggests non-random 
selection of providers opting to participate in ACO initiatives. In the post-ACO adop-
tion period, hospitals that were part of jointly-led ACOs had the lowest cost growth, 
suggesting that this ACO structure may be the most effective.
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Objectives: Determine 30-day, 60-day and 90-day readmission pattern in patients 
hospitalized for heart failure (HF). MethOds: A 5% (n= 3,493,434) national sample 
of Medicare beneficiaries was used to assess the frequency of all-cause readmission 
following an HF hospitalization. The data were restricted to individuals enrolled 
in fee-for-service Medicare (not in Medicare Advantage) who were hospitalized at 
least once with a primary diagnosis of HF between July 1, 2005 and December 31, 
2011. For all HF hospitalizations observed during the study period, 30-, 60-, and 
90-day all-cause readmission rates were calculated. For those hospitalizations that 
were followed by subsequent admissions, the median time to readmission was 
also calculated. Results: During the study period, 82,825 individuals experienced 
a total of 134,328 HF hospitalizations. For those 134,328 episodes, 29,998 (22.3%) 
experienced all-cause readmission within 30 days of discharge. The median time to 
readmission was 14 days. The 60-day readmission rate increased to 33.3% (n= 44,720). 
The results indicated that 40.2% of the episodes experienced readmission within 
90-days and the median time to 90-day readmission was 37 days. cOnclusiOns: 
Individuals hospitalized for HF are frequently readmitted. Approximately 1 in 4 
hospitalizations will be followed by a readmission within 30 days, of which half 
would occur within 2 weeks.
diSeaSe-SPecific StudieS
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effectiveneSS of PHarMacotHeraPy in cHildren witH SyMPtoMatic 
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Objectives: Majority of the studies on epilepsy have been done on adults and few 
studies are available on children with symptomatic epilepsy (SE). This study aims 
to fill this gap by analyzing the effectiveness of anti epileptic drug (AED) therapy in 
children with SE. MethOds: Study was conducted in pediatric outpatient neurology 
clinic of public tertiary care hospital. Children aged 2-18 undergoing AED treatment ≥ 
3 months and diagnosed with SE were included. Effectiveness parameters included; 
complete seizure remission (CSR) for 2 years and adverse drug reactions (ADRs). Those 
children who achieved CSR for 2 years with normalization of electroencephalogram 
were eligible to stop AED treatment. Children were followed for 2 years. Results: 123 
children who completed the follow up were included; 73 (59%) were boys and mean 
(SD) age of children was 8.48±0.43 yrs. The major cause was Neurocysticercosis (NCC) 
in 77 (63%), followed by cryptogenic epilepsy 25 (20%), birth asphyxia 7 (6%), infection 
4 (3%), congenital structural defects 3 (3%) tuberculoma 3 (2.4%) and stroke and hypoc-
alcemia in 2 (1.6%) children each. 79 children (64%) were on monotherapy. 80 (65%) 
were prescribed phenytoin, 25 (20.3%) sodium valproate and 18 (15%) carbamazepine. 
70 (57%) children were prescribed albendazole-prednisolone. At follow-up, 82 (67%) 
children had CSR but AED could be stopped in 62 (50%) only. ADRs were reported in 
27 (22%) children. cOnclusiOns: NCC is the major cause of symptomatic epilepsy 
in North India. The pharmacotherapy, primarily being phenytoin is well tolerated and 
efficacious in children with SE. Though two-third of the children had CSR only 50% 
were eligible to stop AED treatment. This study could serve as the basis to determine 
how the treatment of SE differs from idiopathic Epilepsy and whether or not a differ-
ent approach is required to treat children.
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coMParative Study of tHe influence of biaPeneM and MeroPeneM on 
valProic acid blood concentration
Tang L.
Suzhou Municipal Hospital, Suzhou, China
Objectives: Several studies have described a remarkable interaction between 
Meropenem and Valproic acid (VPA). However, there’s no analysis has been con-
ducted evaluating the influence of different carbapenems on VPA blood level. 
We sought to analyze the influence of Biapenem on VPA blood concentration 
and the risk of seizures. MethOds: We retrospectively collected the patients 
who concomitant administrated of VPA and Biapenem, Meropenem as the con-
trol group::Biapenem 37 cases and Meropenem 48 cases. Recorded the informa-
tion as follows: general clinical data, medication, VPA concentration, seizures 
and treatment and so on. Results: Both of Biapenem and Meropenem signifi-
cantly decreased the VPA blood level . The lowest concentrations in Biapenem 
group were higher than Meropenem group(P= 0.046). The mean decrease of VPA 
level in Biapenem group was also less than Meropenem group (70.65±9.64% 
vs 78.83±8.78%,P= 0.01). There were six patients treated with Biapenem and 
Meropenem at different times of infection during taken the VPA. The low-
95% CI= 0.41-0.52; p< 0.0001). cOnclusiOns: Outpatient follow-up within 7 days 
after hospitalization for mental illness was associated with statistically significant 
lower likelihood of 30-day re-admission.
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Objectives: Problems were lack of a coordinated approach to review and approval 
of order sets across the 4-hospital division; lack of consistent formal review pro-
cess; wide variability in utilization of order sets, and therefore opportunities 
for errors and misalignment with regulatory compliance. Order set review and 
approval cycle time (defined as from the time an order set is drafted or received 
from the system level to when the approval bodies have approved it and it is 
ready for build, QA, and implementation) was also lengthy, impacting key stake-
holder satisfaction and deployment of order sets for Computerized Physician 
Order Entry (CPOE). Objectives were to create one improved process for all four 
hospitals within the division, with 100% of new order sets compliant with the 
improved process going forward, process cycle time decreased to less than 60 days 
initially, and an increase in staff understanding of terms. MethOds: Methods 
utilized to improve the process included Lean Six Sigma tools such as project 
charter, Voice of the Customer (VOC), stakeholder analysis, communication plans, 
SIPOC, elevator speeches, project work plan, Value Stream Mapping of the current 
and future processes, data definitions and collection plan, data analysis includ-
ing XmR control charts and capability analyses, fishbone/cause and effect dia-
gram, Improvement Plan, Control Plan, and computer-based learning of order 
set terminology. Results: Following successful phased implementation of the 
improved process, results were a decrease in cycle time from an average of 77.1 
days at baseline to an average of 18.1 days in the post-improvement data collec-
tion period. cOnclusiOns: In addition to decreased cycle time, the benefits of 
an improved process to review and approve order sets include decreased colleague 
time spent on the process, increased colleague understanding of terms and pro-
cess due to developed education, increased goodwill with physicians due to more 
timely approval of requested order sets, potential decrease in regulatory issues 
and increase in quality of care, and improved CPOE adoption.
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Objectives: Treatment rates for mental health and substance use disorder (MH/
SUD) conditions are low in the U.S. We assessed consumers’ monetary valuation of 
primary care and collaborative care models for treating MH/SUD relative to usual 
care as a potential strategy for improving treatment rates. MethOds: We conducted 
a national, survey-embedded randomized vignette experiment of individuals with 
untreated MH/SUD in 2013. 58,928 adults were screened online and categorized as 
meeting criteria for either drug abuse (N= 418) or alcohol abuse (N= 698) based on 
DSM-IV criteria, or a mental health disorder based on a positive K6 score (N= 1,030). 
The 2,146 participants were randomized to view one of three treatment vignettes: 
usual care (N= 726), primary care (N= 697), or collaborative care (N= 723). Participants 
were asked whether they would be willing to enter treatment first if it were free to 
them, and then if they had to pay (for those initially indicating they were willing, 
randomly assigned as $10, $30 or $50) or were paid (for those initially indicating 
they were not willing, randomly assigned in $5 increments between $5 and $25). 
Responses were aggregated to calculate, for each treatment approach, an inverse 
demand function (i.e., proportion of all participants willing to enter treatment at 
each price point). After adjusting for MH/SUD condition, we fit linear regression 
lines through the inverse demand curves. Participants’ average incremental value 
was calculated as the horizontal distance between the linearized inverse demand 
functions. Results: Respondents valued primary care over usual care by $9.00 
(95% confidence interval [CI]: $2.97, $15.04; p= 0.003), and they valued collaborative 
care over usual care by $5.85 (95% CI: -$0.14, $11.85; p= 0.056). cOnclusiOns: Our 
results suggest that low treatment rates for MH/SUD may be addressed by increasing 
the availability of primary care and collaborative care treatment models, which are 
somewhat more appealing to consumers than usual care.
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Objectives: Providers who have had favorable cost and quality trends may be 
more likely to form Accountable Care Organizations (ACOs) because they expect 
to profit from changes that are already underway within their organization. We 
examine trends in hospital cost per discharge and in-hospital mortality rates among 
hospitals that formed ACOs and those that did not, incorporating several years of 
data preceding ACO formation. MethOds: We compared growth rates in cost per 
discharge and in-hospital mortality rates for select conditions. Data were from 2008 
to 2011 (pre-ACO) and 2011 to 2012 (post-ACO) for hospitals that did and did not 
implement ACOs. We also explored whether there were distinct trends based on ACO 
leadership structure. Results: Between 2008 and 2011, the average rate of growth 
in cost per discharge for hospitals that adopted ACOs was less than one-third of the 
rate among hospitals that remained unaffiliated (0.59% vs 2.02%). Among ACOs in 
which the hospital assumed a leadership role, mean cost per discharge declined dur-
ing the pre-ACO period at an average rate of 0.55% for hospital-led ACOs and 1.52% 
for jointly-led ACOs. Cost per discharge during the post-ACO period grew at a rate 
of 1.99% among ACO hospitals and 1.02% among non-ACO hospitals. Hospital-led 
